We are live on ! Find out more
ANIK icon

Anika Therapeutics

160 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

19% more capital invested

Capital invested by funds: $405M → $483M (+$77.5M)

5% more funds holding

Funds holding: 153160 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 57

45% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.46M

Holders
160
Holders Change
+7
Holders Change %
+4.58%
% of All Funds
4.27%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
25
Increased
56
Reduced
57
Closed
15
Calls
$1.89M
Puts
$3.46M
Net Calls
-$1.56M
Net Calls Change
-$368K
Name Holding Trade Value Shares
Change
Change in
Stake
Fuller & Thaler Asset Management
26
Fuller & Thaler Asset Management
California
$4.24M +$62.5K +1,600 +2%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$4.07M +$73.5K +1,881 +2%
SGAM
28
Smith Group Asset Management
Texas
$4M -$111K -2,840 -3%
EAM
29
Eagle Asset Management
Florida
$3.95M -$82.4K -2,108 -2%
Principal Financial Group
30
Principal Financial Group
Iowa
$3.58M +$27.3K +699 +0.8%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$3.04M -$354K -9,051 -11%
MOACM
32
Mutual of America Capital Management
New York
$3.02M +$789K +20,184 +37%
Public Employees Retirement Association of Colorado
33
Public Employees Retirement Association of Colorado
Colorado
$2.75M
CM
34
Capital Management
Virginia
$2.73M +$782 +20 +0%
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
$2.72M +$2.04M +52,292 +362%
Ameriprise
36
Ameriprise
Minnesota
$2.68M -$610K -15,611 -19%
CEI
37
Clark Estates Inc
New York
$2.59M +$215K +5,500 +9%
Deutsche Bank
38
Deutsche Bank
Germany
$2.31M +$963K +24,626 +77%
BIM
39
BlackRock Investment Management
Delaware
$2.03M -$10.4K -266 -0.5%
DCM
40
Dupont Capital Management
Delaware
$2.03M -$13.3K -340 -0.7%
Marshall Wace
41
Marshall Wace
United Kingdom
$1.97M -$971K -24,852 -34%
QI
42
QS Investors
New York
$1.95M +$1.87M +47,902 New
JIR
43
James Investment Research
Ohio
$1.88M +$41.2K +1,054 +2%
TAM
44
THB Asset Management
Connecticut
$1.85M +$13.7K +350 +0.8%
SCM
45
Sterling Capital Management
North Carolina
$1.83M -$12.4K -316 -0.7%
Prudential Financial
46
Prudential Financial
New Jersey
$1.71M +$113K +2,900 +7%
VAS
47
Valicenti Advisory Services
New York
$1.69M +$5.86K +150 +0.4%
Morgan Stanley
48
Morgan Stanley
New York
$1.65M -$4.66M -119,254 -75%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.65M +$1.58M +40,495 New
BWFA
50
Baltimore-Washington Financial Advisors
Maryland
$1.64M +$568K +14,535 +56%

ANIK Hedge Fund Activity: Q4 2014 in Review

160 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2014, worth a combined $483M — up 19% from $405M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ANIK positions and 15 closed out — a net gain of 10 holders — while 56 added to existing stakes and 57 trimmed.

The largest buyer was Ranger Investment Management, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $8.04M.

  • 160 institutional investors held Anika Therapeutics (ANIK) as of Q4 2014, up from 153 in Q3 2014.
  • Funds reported $483M of Anika Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 25 funds opened new Anika Therapeutics positions in Q4 2014 and 15 closed out, a net change of +10 holders.
  • The largest Anika Therapeutics buyer in Q4 2014 was Ranger Investment Management, an estimated $15.4M added.
  • The largest Anika Therapeutics seller in Q4 2014 was Millennium Management, an estimated $8.04M sold.

Based on aggregated 13F filings for Q4 2014.